Xeris Pharmaceuticals Inc reported $318.62M in Assets for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Assets Change
Acelrx Pharmaceuticals ACRX:US $ 56.13M 15.84M
Eli Lilly And LLY:US $ 47063.6M 144.3M
Endo International Ordinary Shares ENDP:US $ 6362.26M 2084.95M
Horizon Pharma HZNP:US $ 8853.47M 113.14M
JAZZ PHA JAZZ:US $ 11200.13M 568.78M
Nektar Therapeutics NKTR:US $ 861.99M 162.13M
Pacira Pharmaceuticals PCRX:US $ 1733.99M 157.49M
Perrigo Ordinary Shares PRGO:US $ 10919.6M 530.1M
Supernus Pharmaceuticals SUPN:US $ 1694.97M 55.46M
Teva Pharmaceutical Industries TEVA:US $ 45932M 1127M